|Bid||43.41 x 1000|
|Ask||43.74 x 800|
|Day's Range||43.08 - 43.73|
|52 Week Range||28.03 - 48.50|
|Beta (5Y Monthly)||1.15|
|PE Ratio (TTM)||334.38|
|Earnings Date||Feb 26, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||54.00|
Orthofix Announces Board Chair Transition; Catherine Burzik nominated for election as the next Chair of the Company's Board of Directors.
Orthofix's (OFIX) CONSTRUX Mini Ti Spacer System, designed with nanoscale surface is the first 3D-printed titanium interbody, was launched to enhance ACDF procedures.
Orthofix launches the Company’s first 3D-printed titanium cervical interbody, the CONSTRUX™ Mini Ti Cervical Spacer System with Nanovate™ Technology.